𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Met amplification and tumor progression in Cdkn2a-deficient melanocytes

✍ Scribed by Matthew W. VanBrocklin; James P. Robinson; Todd Whitwam; Adam R. Guilbeault; Julie Koeman; Pamela J. Swiatek; George F. Vande Woude; Joseph D. Khoury; Sheri L. Holmen

Book ID
118074699
Publisher
Wiley (Blackwell Publishing)
Year
2009
Tongue
English
Weight
621 KB
Volume
22
Category
Article
ISSN
1755-1471

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutation and expression analyses of the
Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression
✍ Yuyan Chen; Junko Takita; Masashi Mizuguchi; Kiyoshi Tanaka; Kohmei Ida; Katsuyo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB

## Abstract Rhabdomyosarcoma (RMS) is the most common soft‐tissue sarcoma of childhood. The simultaneous loss of __Ink4a__/__Arf__ function and disruption of Met signaling in __Ink4a__/__Arf__^−/−^ mice transgenic for hepatocyte growth factor/scatter factor (__HGF/SF__) induces RMS with extremely h

Altered purinergic signaling in CD73-def
Altered purinergic signaling in CD73-deficient mice inhibits tumor progression
✍ Gennady G. Yegutkin; Fumiko Marttila-Ichihara; Marika Karikoski; Jussi Niemelä; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 1 views

## Abstract CD73/ecto‐5′‐nucleotidase dephosphorylates extracellular AMP into adenosine, and it is a key enzyme in the regulation of adenosinergic signaling. The contribution of host CD73 to tumor growth and anti‐tumor immunity has not been studied. Here, we show that under physiological conditions